Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis

Author:

Le Minh1,Malpas Charles1,Sharmin Sifat1,Horáková Dana2ORCID,Havrdova Eva2,Trojano Maria3,Izquierdo Guillermo4,Eichau Sara4ORCID,Ozakbas Serkan5,Lugaresi Alessandra6,Prat Alexandre7,Girard Marc7,Duquette Pierre7,Larochelle Catherine7,Alroughani Raed8ORCID,Bergamaschi Roberto9,Sola Patrizia10,Ferraro Diana10,Grammond Pierre11,Grand’ Maison Francois12,Terzi Murat13,Boz Cavit14,Hupperts Raymond15,Butzkueven Helmut16,Pucci Eugenio17,Granella Franco18,Van Pesch Vincent19,Soysal Aysun20,Yamout Bassem I.21,Lechner-Scott Jeannette22,Spitaleri Daniele LA23,Ampapa Radek24,Turkoglu Recai25,Iuliano Gerardo26,Ramo-Tello Cristina27,Sanchez-Menoyo Jose Luis28,Sidhom Youssef29,Gouider Riadh29,Shaygannejad Vahid30ORCID,Prevost Julie31,Altintas Ayse32,Fragoso Yara Dadalti33ORCID,McCombe Pamela Ann34,Petersen Thor35,Slee Mark36,Barnett Michael H37ORCID,Vucic Steve38,Van Der Walt Anneke16ORCID,Kalincik Tomas1

Affiliation:

1. CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia; Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia

2. Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic

3. Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy

4. Hospital Universitario Virgen Macarena, Sevilla, Spain

5. Dokuz Eylul University, Konak/Izmir, Turkey

6. IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Riabilitazione Sclerosi Multipla, Bologna, Italy/Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy

7. Centre hospitalier de l’Universite de Montreal (CHUM), Montreal, QC, Canada

8. Division of Neurology, Department of Medicine, Amiri Hospital, Sharq, Kuwait

9. IRCCS Mondino Foundation, Pavia, Italy

10. Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy

11. CISSS de Chaudière-Appalache, Levis, QC, Canada

12. Neuro Rive-Sud, Quebec, QC, Canada

13. Faculty of Medicine, 19 Mayis University, Samsun, Turkey

14. Farabi Hospital, KTU Faculty of Medicine, Trabzon, Turkey

15. Zuyderland Ziekenhuis, Sittard, Netherlands

16. Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia

17. UOC Neurologia, Azienda Sanitaria Unica Regionale Marche–AV3, Macerata, Italy

18. Department of Medicine and Surgery, University of Parma, Parma, Italy

19. Cliniques Universitaires Saint-Luc, Brussels, Belgium

20. Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey

21. Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon

22. School of Medicine and Public Health, The University of Newcastle Australia, Newcastle, NSW, Australia

23. Azienda Ospedaliera di Rilievo Nazionale, San Giuseppe Moscati – Avellino, Avellino, Italy

24. Nemocnice Jihlava, Jihlava, Czech Republic

25. Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey

26. Ospedali Riuniti di Salerno, Salerno, Italy

27. Hospital Germans Trias i Pujol, Barcelona, Spain

28. Hospital de Galdakao-Usansolo, Galdakao, Spain

29. Department of Neurology, Razi Hospital, Manouba, Tunisia

30. Isfahan University of Medical Sciences, Isfahan, Iran, Islamic Republic of

31. CSSS Saint-Jérôme, Saint-Jerome, QC, Canada

32. School of Medicine, Koc University, Istanbul, Turkey

33. Universidade Metropolitana de Santos, Santos, Brazil

34. The University of Queensland, Brisbane, QLD, Australia

35. Kommunehospitalet, Arhus C, Denmark

36. Flinders University, Adelaide, SA, Australia

37. Brain and Mind Centre, The University of Sydney, Camperdown, NSW, Australia

38. Westmead Hospital, Sydney, NSW, Australia

Abstract

Background: Cerebellar and brainstem symptoms are common in early stages of multiple sclerosis (MS) yet their prognostic values remain unclear. Objective: The aim of this study was to investigate long-term disability outcomes in patients with early cerebellar and brainstem symptoms. Methods: This study used data from MSBase registry. Patients with early cerebellar/brainstem presentations were identified as those with cerebellar/brainstem relapse(s) or functional system score ⩾ 2 in the initial 2 years. Early pyramidal presentation was chosen as a comparator. Andersen-Gill models were used to compare cumulative hazards of (1) disability progression events and (2) relapses between patients with and without early cerebellar/brainstem symptoms. Mixed effect models were used to estimate the associations between early cerebellar/brainstem presentations and expanded disability status scale (EDSS) scores. Results: The study cohort consisted of 10,513 eligible patients, including 2723 and 3915 patients with early cerebellar and brainstem symptoms, respectively. Early cerebellar presentation was associated with greater hazard of progression events (HR = 1.37, p < 0.001) and EDSS (β = 0.16, p < 0.001). Patients with early brainstem symptoms had lower hazard of progression events (HR = 0.89, p = 0.01) and EDSS (β = −0.06, p < 0.001). Neither presentation was associated with changes in relapse risk. Conclusion: Early cerebellar presentation is associated with unfavourable outcomes, while early brainstem presentation is associated with favourable prognosis. These presentations may be used as MS prognostic markers and guide therapeutic approach.

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology

Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3